已收盤 07-10 16:00:00 美东时间
-1.500
-2.39%
制药企业CRNX周内劲升97%,获福泰制药百亿美元高溢价收购;PENG周涨27%,Q3财季业绩超预期并上调全年指引;金山云周涨近2成,大摩称其盈利能力持续提升>>
今天 11:01
今日重点评级关注:HC Wainwright & Co.:维持Rockwell Medical"买入"评级,目标价从2美元升至20美元;Canaccord Genuity:维持创力"买入"评级,目标价从10.5美元升至11美元
07-10 17:36
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
07-10 07:11
Truist Securities analyst Peter Osterland upgrades Solstice Advanced Mat (NASDAQ:SOLS) from Hold to Buy and lowers the price target from $90 to $75.
07-09 21:48
Solstice Advanced Materials Inc. (NASDAQ:SOLS) stock edged higher in Tuesday’s premarket trading after plunging 15.14% in the previous session following the company’s announcement that it will acquire Element Solutions Inc. (NYSE:ESI) in a cash-and-stock deal valued at about $14.5 billion. Read Also...
07-07 18:37
Solstice Advanced Materials Inc. (NASDAQ:SOLS) announced Monday that it will acquire Element Solutions Inc. (NYSE:ESI) in a cash-and-stock transaction valued at about $14.5 billion, including assumed net debt. The deal expands Solstice’s presence in electronics, artificial intelligence infrastructur...
07-07 01:21
CNBC’s Jim Cramer strongly endorsed a potential merger between Honeywell International‘s (NASDAQ:HON) spinoff Solstice Advanced Materials Inc. (NASDAQ:SOLS) and Element Solutions Inc. (NYSE:ESI) on Monday. Cramer Backs Megamerger Reacting to financial reports of a $27 billion tie-up, Cramer stated t...
07-06 21:17
今日重点评级关注:Chardan Capital:维持EyePoint"买入"评级,目标价从29美元升至65美元;康托·菲茨杰拉德:维持Hyperliquid Strategies"超配"评级,目标价从8美元升至18.4美元
07-02 18:41
今日重点评级关注:Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元;康托·菲茨杰拉德:维持BioCryst制药"超配"评级,目标价从27美元升至29美元
07-01 10:40
RBC Capital analyst Arun Viswanathan maintains Solstice Advanced Mat (NASDAQ:SOLS) with a Outperform and raises the price target from $100 to $102.
06-30 22:21